Thank you, Glenn. Good morning, everyone. In my prepared remarks today, I will review our full quarter financial results and then provide an outlook for key financial measures for 2025. We ended the year with great momentum. Reaching the $3 billion revenue mark for the first time and delivering strong performance for our stockholders. Starting with term life segment. There to the rate at our financial ratios. Fourth quarter revenue of $451 million increased 4%. The benefits and claims ratio during the fourth quarter of 2024 was 58.6% compared to 58.2% in the prior year. Benefits and claims were adversely affected by a $4.2 million remeasurement loss recognized during the period. That resulted from a refinement to our actuarial model for estimating reserves. Which was not related to any assumption changes. Excluding the model assignment, the benefits and claims ratio was 57.9% favorable to the prior year period. Primarily due to better mortality experience and in line with our full-year guidance, of around 58%. A DAC amortization and insurance commissions ratio at 12.2% was largely consistent with the prior year period. Overall, last rate remained elevated but year-over-year trends appear to be stabilizing. We believe persistency will normalize over time. While we recognize that higher can constrain future ADP growth, they have not meaningfully affected our key financial ratios. The fourth quarter insurance expense ratio increased from 7.1% in the prior year period to 8% in 2024. This year-over-year change was driven primarily by increased variable expenses, associated with growth in direct premiums, recruiting and licensing, higher performance-based employee incentive compensation, as well as higher ongoing technology investments in digital tools. Finally, the Term Life operating margin was 21.3% compared to 22.6% in the prior year period. Well, pre-tax income remains unchanged year over year. As we look ahead, we expect ACP growth of around 5% in 2025. We believe the benefits and claims ratio and the DACs amortization and insurance commissions ratio will remain stable at around 58% and 12% respectively. For the full year, we expect the operating margin to be around 22%. Although we foresee some level of variability due to the normal seasonality inherent in insurance expenses. As a reminder, our first quarter expenses are usually higher due to the annual grant of management equity awards to the retirement eligible employees that are fully expensed when granted. As well as other annual employee-related and operational expenses unique to the first quarter. Turning next to the investment and savings product segment. Fourth quarter revenues of $286 million increased 29% due to a combination of favorable equity market conditions driving client asset values higher and strong demand for our investment solutions. Pretax income of $82 million increased 31%. Sales-based revenues increased 42% while revenue-generating sales rose 39%. Revenues grew at a higher rate than sales due to continued strong demand for variable annuity, while sales save commission expenses generally rose in line with correlated sales. Asset-based revenue increased 27% slightly outpacing the growth in average client asset Valley. Due to continued growth in the US managed accounts, and Canadian mutual funds sold under the proprietary distributor model for which we earn higher asset base fee. Asset base commission expenses grew at similar pace to correlated revenues when including commissions on Canadian segregated funds which are recognized as insurance commissions and debt amortization. The corporate and other distributed product segment incurred a pre-tax adjusted operating loss of $1 million during the fourth quarter of 2024 compared to a pretax adjusted operating loss of $5.4 million in the prior year period. The improvement was due in part to a $3.3 million adjustment to the ceded reserve for a closed block of non-term life insurance business in the prior year period, and the $2.6 million of higher net investment income the settlement continues to benefit from higher yielding investments, and the growth in the size of the portfolio. The segment also incurred higher operating expenses which I will address shortly when I review total consolidated operating expenses. Our invested asset portfolio ended the year with a net unrealized loss of $206 million versus the net unrealized loss of $131 million the end of September. Believe the change in unrealized losses during the quarter was a function of interest rate movement and not underlying credit concerns. And we have no present intention to dispose of them. The portfolio is well diversified and of high quality with an average rating of eight. Finally, fourth quarter consolidated insurance and other operating expenses were $152 million up 13% year over year. The primary drivers of expense growth or higher variable cost associated with growth of our ISP and term life segment higher employee-related incentive compensation, due to the company's overall strong performance in 2024, as well as increased investments on technology. Looking ahead to 2025, we expect full-year consolidated insurance and other operating expenses to increase by around $40 million or 6% to 8%. This includes $12 million to support the growth in the business, $12 million in higher employee staffing costs and $16 million higher technology costs. As I mentioned earlier, we expect operating expenses on a dollar basis to be elevated in the first quarter with year-over-year growth rate in line with our full-year guidance. We also expect fourth quarter 2025 expenses to normalize compared to prior year, due to strong performance, driven in 2024 higher expenses. Moving to our capital position. The holding company had cash and the invested asset. Of $497 million at the end of December 2024. As of December 31st, 2024, Primerica Life estimated RBC ratio was 430%. With that, operator, I open the line for questions.